» Articles » PMID: 39840219

Reversible Dilated Cardiomyopathy Associated With Herpes Simplex Virus Infection: A Case Report

Overview
Journal Cureus
Date 2025 Jan 22
PMID 39840219
Authors
Affiliations
Soon will be listed here.
Abstract

Dilated cardiomyopathy (DCM) is a serious condition often leading to acute heart failure (HF), with diverse etiologies including viral myocarditis. This report details a case of reversible DCM in a 34-year-old male who presented with symptoms of acute HF. Diagnostic workup revealed biventricular dilation with severe systolic dysfunction and serology confirming herpes simplex virus infection. The patient was treated with standard HF therapy and colchicine, leading to significant clinical improvement. Despite the positive viral serology, antiviral therapy was not initiated due to the patient's marked recovery, underscoring the controversial role of antivirals in viral myocarditis-associated DCM. At a one-year follow-up, the patient demonstrated substantial recovery of cardiac function. This case highlights the potential for favorable outcomes with comprehensive management, even in the absence of antiviral therapy, and emphasizes the need for individualized treatment strategies in DCM related to viral myocarditis.

References
1.
Halliday B, Wassall R, Lota A, Khalique Z, Gregson J, Newsome S . Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial. Lancet. 2018; 393(10166):61-73. PMC: 6319251. DOI: 10.1016/S0140-6736(18)32484-X. View

2.
Deng Y, Zhang N, Hua W, Cheng S, Niu H, Chen X . Nomogram predicting death and heart transplantation before appropriate ICD shock in dilated cardiomyopathy. ESC Heart Fail. 2022; 9(2):1269-1278. PMC: 8934923. DOI: 10.1002/ehf2.13808. View

3.
Gentile P, Merlo M, Cannata A, Gobbo M, Artico J, Stolfo D . Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History. J Am Heart Assoc. 2019; 8(17):e010705. PMC: 6755837. DOI: 10.1161/JAHA.118.010705. View

4.
Chimenti C, Russo M, Frustaci A . Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy: 20-year follow-up of the TIMIC trial. Eur Heart J. 2022; 43(36):3463-3473. PMC: 9492235. DOI: 10.1093/eurheartj/ehac348. View

5.
Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P . Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2007; 29(2):270-6. DOI: 10.1093/eurheartj/ehm342. View